Duke University competitive analysis

Loading summary...

Explore Duke University's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 23, 2025
Patent NumberGrant DateTitleTotal Oppositions
Dec 13, 2023Anti-Lypd3 Car T-Cell Therapy For The Treatment Of Cancer1
Dec 6, 2023Methods Of Treating Autism Spectrum Disorders Using Human Umbilical Cord Tissue-Derived Mesenchymal Stromal Cells1
Jan 18, 2023Method Of Treating Cancer Using Selective Estrogen Receptor Modulators2
May 20, 2020Tert Promoter Mutations In Gliomas And A Subset Of Tumors1

Latest publications and patents of Duke University New

Explore the latest publications and patents granted to Duke University, showcasing their recent innovations and technological advancements.

Last updated on: Oct 16, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Duke University

Dec 13, 2023Anti-Lypd3 Car T-Cell Therapy For The Treatment Of CancerRevoked
Dec 6, 2023Methods Of Treating Autism Spectrum Disorders Using Human Umbilical Cord Tissue-Derived Mesenchymal Stromal CellsGranted And Under Opposition
Jan 18, 2023Method Of Treating Cancer Using Selective Estrogen Receptor ModulatorsGranted And Under Opposition
May 20, 2020Tert Promoter Mutations In Gliomas And A Subset Of TumorsRevoked
Jan 3, 2018Method For Splitting Droplets By Electrowetting-Based TechniquesNo Opposition Filed Within Time Limit
Jan 3, 2018Consensus/Ancestral ImmunogensNo Opposition Filed Within Time Limit
Mar 24, 2011Improved Device And Method For Delivery Of A Medicament -
Sep 23, 2010Tobacco-Based Nicotine Aerosol Generation System -
Oct 9, 2008Device And Method For Delivery Of A Medicament -
Oct 2, 2008Device And Method For Delivery Of A Medicament -

Latest PTAB cases involving Duke University

Discover the latest PTAB cases involving Duke University, highlighting their recent legal challenges and patent disputes.

Last updated on: Oct 22, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Duke University

IPR2013-00535Aug 28, 2013BIOMARIN PHARMACEUTICALDUKE UNIVERSITYFinal Written Decision

Peer Comparison New

IP litigation analysis comparing Duke University with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
DUKE UNIVERSITY - 5 - 1
BIOMARIN PHARMACEUTICAL - 183 -
BUHLER13 - - -
HEMSATH3 - - -